Ameritas Investment Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.2K | Sell |
7,093
-553
| -7% | -$7.73K | ﹤0.01% | 1766 |
|
|
2025
Q1 | $103K | Hold |
7,646
| – | – | ﹤0.01% | 1682 |
|
|
2024
Q4 | $147K | Buy |
7,646
+1,516
| +25% | +$29.1K | ﹤0.01% | 1519 |
|
|
2024
Q3 | $139K | Hold |
6,130
| – | – | ﹤0.01% | 1572 |
|
|
2024
Q2 | $79.8K | Buy |
6,130
+1,169
| +24% | +$15.2K | ﹤0.01% | 1871 |
|
|
2024
Q1 | $86.9K | Buy |
4,961
+799
| +19% | +$14K | ﹤0.01% | 1826 |
|
|
2023
Q4 | $90.6K | Hold |
4,162
| – | – | ﹤0.01% | 1806 |
|
|
2023
Q3 | $63.8K | Buy |
4,162
+677
| +19% | +$10.4K | ﹤0.01% | 1950 |
|
|
2023
Q2 | $82.9K | Buy |
3,485
+459
| +15% | +$10.9K | ﹤0.01% | 1722 |
|
|
2023
Q1 | $77K | Hold |
3,026
| – | – | ﹤0.01% | 1701 |
|
|
2022
Q4 | $108K | Buy |
3,026
+1,091
| +56% | +$38.9K | ﹤0.01% | 1537 |
|
|
2022
Q3 | $39K | Hold |
1,935
| – | – | ﹤0.01% | 2159 |
|
|
2022
Q2 | $22K | Buy |
+1,935
| New | +$22K | ﹤0.01% | 2516 |
|
|
2019
Q2 | – | Sell |
-74
| Closed | -$3K | – | 3108 |
|
|
2019
Q1 | $3K | Hold |
74
| – | – | ﹤0.01% | 2923 |
|
|
2018
Q4 | $3K | Hold |
74
| – | – | ﹤0.01% | 2920 |
|
|
2018
Q3 | $6K | Hold |
74
| – | – | ﹤0.01% | 2934 |
|
|
2018
Q2 | $7K | Hold |
74
| – | – | ﹤0.01% | 2905 |
|
|
2018
Q1 | $8K | Buy |
+74
| New | +$8K | ﹤0.01% | 2795 |
|